Visits | Screening | 1st week | 2nd week | 3rd week | 4th week |
---|---|---|---|---|---|
Weeks | −1 | 1 | 2 | 3 | 4 |
Informed consent | X | Â | Â | Â | Â |
Inclusion and exclusion criteria | X | X | Â | Â | Â |
Medical history | X | Â | Â | Â | Â |
Medical evaluation/physical examination (BP measure) | X | X | X | X | X |
Randomization | Â | X | Â | Â | Â |
Application of TENS (3x/week) | Â | X | X | X | X |
Creatinine | X | Â | Â | Â | X |
Fasting glucose | X | Â | Â | Â | X |
Glycated hemoglobin | X | Â | Â | Â | X |
Potassium | X | Â | Â | Â | X |
Uric acid | X | Â | Â | Â | X |
Insulin | X | Â | Â | Â | X |
Total cholesterol | X | Â | Â | Â | X |
HDL-c | X | Â | Â | Â | X |
Triglycerides | X | Â | Â | Â | X |
Urinary sodium | X | Â | Â | Â | X |
Urinary potassium | X | Â | Â | Â | X |
Microalbuminuria | X | Â | Â | Â | X |
GFR estimation | X | Â | Â | Â | X |
Specific biochemistry tests | Â | X | Â | Â | X |
Ambulatory blood pressure monitoring | Â | X | Â | Â | X |
24-h electrocardiographic monitoring | Â | X | Â | Â | X |
Evaluation of sympathetic activity | Â | X | Â | Â | X |
Evaluation of endothelial function | Â | X | Â | Â | X |
Evaluation of arterial stiffness | Â | X | Â | Â | X |